Here are the top stories from the last week:

Industry Updates

How Pharmacists Can Lead the Way in Patient Nutrition and Wellness
Lara Zakaria, PharmD, introduces the topic of pharmaconutrition, urging pharmacists to integrate food, lifestyle, and gut health into patient care through evidence-based, practical interventions. Read article »

IQVIA Releases “Global Use of Medicines Outlook through 2029” Report
IQVIA’s report forecasts the global use of medicines through 2029, highlighting growth in oncology, immunology, diabetes, and obesity drugs. The report discusses trends in drug spending, the impact of innovative therapeutics, and regional differences in medicine use. Read article »

With Proper Adherence to Cholesterol-Lowering Drugs, Thousands of Cardiovascular Events Could Be Avoided
By closing the gap on patients recommended lipid-lowering therapies who do not receive them, researchers say that thousands of cardiovascular events could be prevented and billions of dollars would be saved. Read article »

Clover Health launches New Jersey Community Pharmacy Program in partnership with IPC’s iCare+ Network
Learn more about Clover Health’s new program in New Jersey, which partners with IPC’s iCare+ Network to support community pharmacies. Read article »

GoodRx Releases Analysis on 2025 FDA Generics, Brand Drug Approvals
GoodRx’s analysis highlights a growing disconnect between FDA-approved generics and their actual market accessibility. The report discusses the impact of patent and market barriers on the launch of generics, the slower pace of novel drug approvals, and the potential for over-the-counter switches for certain medications. Read article »

Reassessing the Safety and Efficacy of Very Low LDL Cholesterol
Though cholesterol-lowering guidance often touts the achievement of very low levels of low-density lipoprotein (LDL) cholesterol, emerging research demonstrates possible safety risks. Read article »

Groups Join the Biosimilars Council and AAM Letter of Support for Interchangeability Legislation
Learn more about 39 groups supporting the Biosimilar Red Tape Elimination Act, aimed at improving biosimilar interchangeability. Read article »

NCPA: New “PBM Reform Act” Must Pass ASAP
The National Community Pharmacists Association (NCPA) is advocating for the swift passage of the “PBM Reform Act” after previous PBM reform provisions were excluded from budget reconciliation negotiations. Read article »

Maternal Pro-Inflammatory Diet During Pregnancy Linked to Increased Type 1 Diabetes Risk in Offspring
A maternal pro-inflammatory diet during pregnancy raises the risk of offspring developing type 1 diabetes, highlighting the impact of nutrition on early health. Read article »

Major Insurance Change Hits Users of Zepbound for Weight Loss
Millions of patients using GLP-1 drugs for weight loss may face increased costs due to a major insurance change. Read article »

Drug, Technology & Treatment Updates

FDA Grants Full Approval to mRNA-1273 COVID-19 Vaccine in Children at Increased Risk
mRNA-1273, marketed as Spikevax by Moderna, is now fully approved for individuals aged 6 months through 64 years with high-risk features for severe COVID-19. Read article »

Lupin Launches Ipratropium Bromide Nasal Solution
Learn about the launch of Lupin’s ipratropium bromide nasal solution, a bioequivalent to Atrovent Nasal Spray. Read article »

‍